<?xml version="1.0"?>
<presentation title="12 Jong Kyun Lee" width="720.0000000" height="540.0000000" thmbWidth="78.0000000" thmbHeight="59.0000000" frameRate="24.0000000" looping="0" startingSlideShow="" pptVersion="2010" type="compound" hasExternalAudio="0" uid="{C6DEFA30-7612-4C19-8C71-E1939E05EB9B}">
	<presenters>
		<presenter name="Jong Kyun Lee" title="Korea" email="" web="" phone="" photoAssetId="">
			<bio>Drainage in Malignant Biliary Obstruction
- ERCP first</bio>
		</presenter>
	</presenters>
	<references/>
	<soundAssets>
		<soundAsset id="sndAsset0" src="sound1.mp3" embedded="0" size="286034" duration="10215"/>
		<soundAsset id="sndAsset1" src="sound2.mp3" embedded="0" size="879954" duration="31426"/>
		<soundAsset id="sndAsset2" src="sound3.mp3" embedded="0" size="830948" duration="29676"/>
		<soundAsset id="sndAsset3" src="sound4.mp3" embedded="0" size="882148" duration="31505"/>
		<soundAsset id="sndAsset4" src="sound5.mp3" embedded="0" size="528868" duration="18888"/>
		<soundAsset id="sndAsset5" src="sound6.mp3" embedded="0" size="768776" duration="27456"/>
		<soundAsset id="sndAsset6" src="sound7.mp3" embedded="0" size="868251" duration="31008"/>
		<soundAsset id="sndAsset7" src="sound8.mp3" embedded="0" size="264822" duration="9457"/>
		<soundAsset id="sndAsset8" src="sound9.mp3" embedded="0" size="434514" duration="15518"/>
		<soundAsset id="sndAsset9" src="sound10.mp3" embedded="0" size="1440959" duration="51462"/>
		<soundAsset id="sndAsset10" src="sound11.mp3" embedded="0" size="390628" duration="13951"/>
		<soundAsset id="sndAsset11" src="sound12.mp3" embedded="0" size="540571" duration="19306"/>
		<soundAsset id="sndAsset12" src="sound13.mp3" embedded="0" size="841188" duration="30042"/>
		<soundAsset id="sndAsset13" src="sound14.mp3" embedded="0" size="433782" duration="15492"/>
		<soundAsset id="sndAsset14" src="sound15.mp3" embedded="0" size="422811" duration="15100"/>
		<soundAsset id="sndAsset15" src="sound16.mp3" embedded="0" size="512045" duration="18287"/>
		<soundAsset id="sndAsset16" src="sound17.mp3" embedded="0" size="710994" duration="25392"/>
		<soundAsset id="sndAsset17" src="sound18.mp3" embedded="0" size="601279" duration="21474"/>
		<soundAsset id="sndAsset18" src="sound19.mp3" embedded="0" size="737325" duration="26333"/>
		<soundAsset id="sndAsset19" src="sound20.mp3" embedded="0" size="555931" duration="19854"/>
		<soundAsset id="sndAsset20" src="sound21.mp3" embedded="0" size="374536" duration="13376"/>
		<soundAsset id="sndAsset21" src="sound22.mp3" embedded="0" size="676616" duration="24164"/>
		<soundAsset id="sndAsset22" src="sound23.mp3" embedded="0" size="683199" duration="24399"/>
		<soundAsset id="sndAsset23" src="sound24.mp3" embedded="0" size="484982" duration="17320"/>
		<soundAsset id="sndAsset24" src="sound25.mp3" embedded="0" size="422811" duration="15100"/>
		<soundAsset id="sndAsset25" src="sound26.mp3" embedded="0" size="46856" duration="1673"/>
	</soundAssets>
	<sharedAssetsLibrary src="assets.swf"/>
	<graphicAssets>
		<graphicAsset id="imgAsset0" src="thmb1.swf" embedded="0"/>
		<graphicAsset id="imgAsset1" src="thmb2.swf" embedded="0"/>
		<graphicAsset id="imgAsset2" src="thmb3.swf" embedded="0"/>
		<graphicAsset id="imgAsset3" src="thmb4.swf" embedded="0"/>
		<graphicAsset id="imgAsset4" src="thmb5.swf" embedded="0"/>
		<graphicAsset id="imgAsset5" src="thmb6.swf" embedded="0"/>
		<graphicAsset id="imgAsset6" src="thmb7.swf" embedded="0"/>
		<graphicAsset id="imgAsset7" src="thmb8.swf" embedded="0"/>
		<graphicAsset id="imgAsset8" src="thmb9.swf" embedded="0"/>
		<graphicAsset id="imgAsset9" src="thmb10.swf" embedded="0"/>
		<graphicAsset id="imgAsset10" src="thmb11.swf" embedded="0"/>
		<graphicAsset id="imgAsset11" src="thmb12.swf" embedded="0"/>
		<graphicAsset id="imgAsset12" src="thmb13.swf" embedded="0"/>
		<graphicAsset id="imgAsset13" src="thmb14.swf" embedded="0"/>
		<graphicAsset id="imgAsset14" src="thmb15.swf" embedded="0"/>
		<graphicAsset id="imgAsset15" src="thmb16.swf" embedded="0"/>
		<graphicAsset id="imgAsset16" src="thmb17.swf" embedded="0"/>
		<graphicAsset id="imgAsset17" src="thmb18.swf" embedded="0"/>
		<graphicAsset id="imgAsset18" src="thmb19.swf" embedded="0"/>
		<graphicAsset id="imgAsset19" src="thmb20.swf" embedded="0"/>
		<graphicAsset id="imgAsset20" src="thmb21.swf" embedded="0"/>
		<graphicAsset id="imgAsset21" src="thmb22.swf" embedded="0"/>
		<graphicAsset id="imgAsset22" src="thmb23.swf" embedded="0"/>
		<graphicAsset id="imgAsset23" src="thmb24.swf" embedded="0"/>
		<graphicAsset id="imgAsset24" src="thmb25.swf" embedded="0"/>
		<graphicAsset id="imgAsset25" src="thmb26.swf" embedded="0"/>
	</graphicAssets>
	<backgroundSound soundAssetId="" looping="0" volume="1.0000000"/>
	<narration>
		<audioTracks>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset0">
				<startTimestamp slideIndex="0" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="0" stepIndex="0" timeOffset="10.1770000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset1">
				<startTimestamp slideIndex="1" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="1" stepIndex="0" timeOffset="31.3980000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset2">
				<startTimestamp slideIndex="2" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="2" stepIndex="0" timeOffset="29.6299992"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset3">
				<startTimestamp slideIndex="3" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="3" stepIndex="0" timeOffset="31.4650000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset4">
				<startTimestamp slideIndex="4" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="4" stepIndex="0" timeOffset="18.8519993"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset5">
				<startTimestamp slideIndex="5" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="5" stepIndex="0" timeOffset="27.4270000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset6">
				<startTimestamp slideIndex="6" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="6" stepIndex="0" timeOffset="30.9640000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset7">
				<startTimestamp slideIndex="7" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="7" stepIndex="0" timeOffset="9.4090000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset8">
				<startTimestamp slideIndex="8" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="8" stepIndex="0" timeOffset="15.4820000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset9">
				<startTimestamp slideIndex="9" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="9" stepIndex="0" timeOffset="51.4179993"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset10">
				<startTimestamp slideIndex="10" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="10" stepIndex="0" timeOffset="13.9139996"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset11">
				<startTimestamp slideIndex="11" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="11" stepIndex="0" timeOffset="19.2530000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset12">
				<startTimestamp slideIndex="12" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="12" stepIndex="0" timeOffset="29.9970000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset13">
				<startTimestamp slideIndex="13" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="13" stepIndex="0" timeOffset="15.4490000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset14">
				<startTimestamp slideIndex="14" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="14" stepIndex="0" timeOffset="15.0480000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset15">
				<startTimestamp slideIndex="15" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="15" stepIndex="0" timeOffset="18.2520000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset16">
				<startTimestamp slideIndex="16" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="16" stepIndex="0" timeOffset="25.3589993"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset17">
				<startTimestamp slideIndex="17" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="17" stepIndex="0" timeOffset="21.4209995"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset18">
				<startTimestamp slideIndex="18" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="18" stepIndex="0" timeOffset="26.2929993"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset19">
				<startTimestamp slideIndex="19" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="19" stepIndex="0" timeOffset="19.8199997"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset20">
				<startTimestamp slideIndex="20" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="20" stepIndex="0" timeOffset="13.3470000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset21">
				<startTimestamp slideIndex="21" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="21" stepIndex="0" timeOffset="24.1240000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset22">
				<startTimestamp slideIndex="22" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="22" stepIndex="0" timeOffset="24.3579998"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset23">
				<startTimestamp slideIndex="23" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="23" stepIndex="0" timeOffset="17.2840000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset24">
				<startTimestamp slideIndex="24" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="24" stepIndex="0" timeOffset="15.0480000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset25">
				<startTimestamp slideIndex="25" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="25" stepIndex="0" timeOffset="1.6350000"/>
			</audioTrack>
		</audioTracks>
	</narration>
	<settings>
		<navigation>
			<keyboard enabled="1">
				<actions>
					<action name="playPause">
						<shortcut code="32" control="0" shift="0"/>
					</action>
					<action name="nextSlide">
						<shortcut code="34" control="0" shift="0"/>
					</action>
					<action name="previousSlide">
						<shortcut code="33" control="0" shift="0"/>
					</action>
					<action name="nextStep">
						<shortcut code="13" control="0" shift="0"/>
					</action>
					<action name="previousStep">
						<shortcut code="13" control="0" shift="1"/>
					</action>
					<action name="firstSlide">
						<shortcut code="36" control="1" shift="0"/>
					</action>
					<action name="lastSlide">
						<shortcut code="35" control="1" shift="0"/>
					</action>
					<action name="lastViewedSlide">
						<shortcut code="8" control="0" shift="0"/>
					</action>
					<action name="slideStart">
						<shortcut code="36" control="0" shift="0"/>
					</action>
					<action name="slideEnd">
						<shortcut code="35" control="0" shift="0"/>
					</action>
					<action name="seekForward">
						<shortcut code="39" control="0" shift="0"/>
					</action>
					<action name="seekBackward">
						<shortcut code="37" control="0" shift="0"/>
					</action>
					<action name="volumeUp">
						<shortcut code="38" control="0" shift="0"/>
					</action>
					<action name="volumeDown">
						<shortcut code="40" control="0" shift="0"/>
					</action>
					<action name="toggleFullscreen">
						<shortcut code="70" control="1" shift="0"/>
					</action>
				</actions>
			</keyboard>
			<mouse enabled="1" target="step"/>
			<gesture zoom="1"/>
		</navigation>
		<skin>
			<colorSettings>
				<color id="button.content.normal">#FFFFFF</color>
				<color id="button.content.over">#FFFFFF</color>
				<color id="button.face.normal">#777777</color>
				<color id="button.face.over">#575757</color>
				<color id="companyLogo.background">#FFFFFF</color>
				<color id="hyperlink">#097CE7</color>
				<color id="listItem.face.over">#E8E8E8</color>
				<color id="listItem.face.pressed">#6E6E6E</color>
				<color id="listItem.label.over">#000000</color>
				<color id="listItem.label.pressed">#FFFFFF</color>
				<color id="listItem.label.visited">#A1A1A1</color>
				<color id="page.background">#8A8A8A</color>
				<color id="panel.background">#F7F7F7</color>
				<color id="panel.text">#323232</color>
				<color id="player.background">#D4D4D4</color>
				<color id="popup.background">#FFFFFF</color>
				<color id="progress.background">#6E6E6E</color>
				<color id="progress.loading">#D0D0D0</color>
				<color id="progress.playback">#A1A1A1</color>
				<color id="text">#4D4D4D</color>
			</colorSettings>
			<controlPanelSettings>
				<visible>true</visible>
				<showOutline>false</showOutline>
				<showPlayPause>true</showPlayPause>
				<showRewind>true</showRewind>
				<showVolumeControl>true</showVolumeControl>
				<showCCButton>false</showCCButton>
				<showPrevButton>true</showPrevButton>
				<showNextButton>true</showNextButton>
				<showSlideOnlyButton>true</showSlideOnlyButton>
				<progressBar>
					<visible>true</visible>
					<enabled>true</enabled>
					<showLabels>true</showLabels>
					<mode>slideTimeline</mode>
				</progressBar>
				<navigationMode>bySlides</navigationMode>
			</controlPanelSettings>
			<titlePanelSettings>
				<showLogo>false</showLogo>
				<visible>true</visible>
				<buttons>
					<button type="attachments" visible="false"/>
					<button type="presenterInfo" visible="false"/>
					<button type="markerTools" visible="true"/>
					<button type="notes" visible="false"/>
					<button type="outline" visible="false"/>
				</buttons>
			</titlePanelSettings>
			<outlinePanelSettings>
				<numberEntries>true</numberEntries>
				<highlightViewedEntries>true</highlightViewedEntries>
				<thumbnails>true</thumbnails>
				<search>true</search>
				<multilevel>true</multilevel>
			</outlinePanelSettings>
			<sidePanelSettings>
				<showAtLeft>true</showAtLeft>
				<showLogo>false</showLogo>
				<showPresenterInfo>true</showPresenterInfo>
				<showPresenterVideo>false</showPresenterVideo>
				<visible>true</visible>
				<tabsPanel>
					<showOutline>true</showOutline>
					<showNotes>false</showNotes>
				</tabsPanel>
			</sidePanelSettings>
		</skin>
		<appearance fullScreen="1" showSlidePreloader="1"/>
		<playback autoStart="1" syncWithVideoNarration="1" enableVideoControl="1" resumePresentationPlayback="always"/>
	</settings>
	<slides embedded="0">
		<slide index="0" title="Drainage in Malignant Biliary Obstruction - ERCP First" titleNormalized="drainage in malignant biliary obstruction - ercp first" src="slide1.swf" size="65394" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset0" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="10.1760000"/>
			</animationSteps>
			<notes>too clear to explain for</notes>
			<notesNormalized>too clear to explain for</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;too clear to explain for&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Drainage in Malignant Biliary Obstruction	 - ERCP First	 
EUS Summit 2019
Jong-Kyun Lee, M.D., Ph.D.
Department of Medicine, Samsung Medical Center Sungkyunkwan University School of Medicine Seoul, Korea</text>
		</slide>
		<slide index="1" title="ERCP vs. EUS for malignant biliary obstruction" titleNormalized="ercp vs. eus for malignant biliary obstruction" src="slide2.swf" size="22006" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset1" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="31.3970007"/>
			</animationSteps>
			<notes>Agree with 
will not cover this issue in detail</notes>
			<notesNormalized>agree with 
will not cover this issue in detail</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Agree with &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;will not cover this issue in detail&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>ERCP vs. EUS for malignant biliary obstruction 
The last published guidelines accept the following indications for EUS-BD drainage
Failed ERCP performed by a referral center with high expertise
Inaccessible papilla due to altered anatomy or duodenal obstruction precluding papillary access
contraindication to percutaneous access such as large volume ascites


Teoh AYB, Asian EUS group, Gut 2018
Dumonceau JM, ESGE Guideline, Endoscopy 2018
Mukai S, Tokyo Guidelines, JHPS 2017
Kahaleh M, consortium meeting, WJG 2013</text>
		</slide>
		<slide index="2" title="Surgically altered anatomy" titleNormalized="surgically altered anatomy" src="slide3.swf" size="158479" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset2" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="29.6289992"/>
			</animationSteps>
			<notes>Both ~ are good option for surgically altered anatomy</notes>
			<notesNormalized>both ~ are good option for surgically altered anatomy</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Both ~ are good option for surgically altered anatomy&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Surgically altered anatomy 
&gt;
nonrandomized cohort study 
The rate of adverse events was significantly higher in EUS-BD group
e-ERCP is still standard technique 
EUS-BD is good option in pt. with malignant biliary obstruction and RY reconstruction</text>
		</slide>
		<slide index="3" title="Combined malignant biliary and duodenal obstruction" titleNormalized="combined malignant biliary and duodenal obstruction" src="slide4.swf" size="76425" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset3" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="31.4640002"/>
			</animationSteps>
			<notes>~ is also troublesome condition 
Such as HGS</notes>
			<notesNormalized>~ is also troublesome condition 
such as hgs</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;~ is also troublesome condition &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Such as HGS&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Combined malignant biliary and duodenal obstruction 
In type 2, double stenting is successful less than 50%, so combined duodenal stent and EUS-BD would be a good option
In type 1, 3 duod obst, duodeal stent and ERCP are usually succeeded 
Nakai Y, Isayama H, et al. Dig Endosc 2017</text>
		</slide>
		<slide index="4" title="Issues on ERCP vs. EUS-BD for MBO" titleNormalized="issues on ercp vs. eus-bd for mbo" src="slide5.swf" size="12389" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset4" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="18.8509993"/>
			</animationSteps>
			<notes>These issues may be today’s discussion point</notes>
			<notesNormalized>these issues may be today’s discussion point</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;These issues may be today’s discussion point&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Issues on ERCP vs. EUS-BD for MBO
Primary drainage 
Difficult cannulation
Preoperative vs Palliative 
Distal vs. Hilar obstruction 
Uncertain malignant obstruction</text>
		</slide>
		<slide index="5" title="Is Primary EUS-BD prime time?" titleNormalized="is primary eus-bd prime time?" src="slide6.swf" size="171191" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset5" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="27.4260000"/>
			</animationSteps>
			<notes>The first issue is ~
There are several meta-analysis comparing ERCP and EUS-BD for the primary drainage of MBO 
analyzed 5 studies including 3 RCTs. 2 from Korea and 1 from USA.
Study populations are relatively small 
Most etiologies ~</notes>
			<notesNormalized>the first issue is ~
there are several meta-analysis comparing ercp and eus-bd for the primary drainage of mbo 
analyzed 5 studies including 3 rcts. 2 from korea and 1 from usa.
study populations are relatively small 
most etiologies ~</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;The first issue is ~&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;There are several meta-analysis comparing ERCP and EUS-BD for the primary drainage of MBO &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;analyzed 5 studies including 3 RCTs. 2 from Korea and 1 from USA.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Study populations are relatively small &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Most etiologies ~&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Is Primary EUS-BD prime time? 
Endoscopy 2019</text>
		</slide>
		<slide index="6" title="" titleNormalized="" src="slide7.swf" size="169757" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset6" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="30.9630007"/>
			</animationSteps>
			<notes>Overall technical ~
Regarding the stent occlusion, ~</notes>
			<notesNormalized>overall technical ~
regarding the stent occlusion, ~</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Overall technical ~&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Regarding the stent occlusion, ~&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Technical and clinical success, procedure time were not different
EUS-BD showed less tumor ingrowth, but food impaction and migration rate were higher so that overall stent dysfunction rates were similar
There was no significant difference in overall adverse events
</text>
		</slide>
		<slide index="7" title="" titleNormalized="" src="slide8.swf" size="157609" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset7" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="9.4080004"/>
			</animationSteps>
			<notes>However. there was ~
In particular, Pancreatitis rate ~ This result is fully expected</notes>
			<notesNormalized>however. there was ~
in particular, pancreatitis rate ~ this result is fully expected</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;However. there was ~&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;In particular, Pancreatitis rate ~ This result is fully expected&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>There was a substantial difference regarding the types of adverse events
Pancreatitis rate was lower with EUS-BD approach compared to ERCP 
</text>
		</slide>
		<slide index="8" title="" titleNormalized="" src="slide9.swf" size="141082" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset8" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="15.4810004"/>
			</animationSteps>
			<notes>On the other hand, there were trends ~
In terms of severe adverse events, two perforations ~</notes>
			<notesNormalized>on the other hand, there were trends ~
in terms of severe adverse events, two perforations ~</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;On the other hand, there were trends ~&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;In terms of severe adverse events, two perforations ~&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>There were trends toward increased rates of bile peritonitis, stent migration with the EUS-BD 
Two perforations were reported only within the EUS-BD group</text>
		</slide>
		<slide index="9" title="Primary EUS-BD for malignant biliary obstruction" titleNormalized="primary eus-bd for malignant biliary obstruction" src="slide10.swf" size="31097" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset9" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="51.4169993"/>
			</animationSteps>
			<notes>Although Primary EUS-BD showed comparable outcome and AEs to ERCP </notes>
			<notesNormalized>although primary eus-bd showed comparable outcome and aes to ercp</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Although Primary EUS-BD showed comparable outcome and AEs to ERCP &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>All studies were conducted at tertiary care centers with high level of endoscopic expertise 
Success rate may be lower and AEs higher as the procedure is widely adopted and performed at average-volume centers
Although EUS-BD may avoid post-ERCP pancreatitis, complications associated with EUS-BD are more severe
RCTs included mostly PC with distal obstruction, and the results would be different if more BD ca and hilar obst. are included 
Longitudinal tumor spread may induce tumor ingrowth of CDS stent
Hilar obstruction is more complicated with EUS-BD
Primary EUS-BD for malignant biliary obstruction 
Not yet prime time!</text>
		</slide>
		<slide index="10" title="Accessible papilla , but difficult biliary cannulation" titleNormalized="accessible papilla , but difficult biliary cannulation" src="slide11.swf" size="9097" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset10" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="13.9129996"/>
			</animationSteps>
			<notes>Next issue  
We have 4 options </notes>
			<notesNormalized>next issue 
we have 4 options</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Next issue  &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;We have 4 options &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Precut sphincterotomy 
Second ERCP 
EUS-BD
PTBD 
Accessible papilla , but difficult biliary cannulation</text>
		</slide>
		<slide index="11" title="Precut sphincterotomy" titleNormalized="precut sphincterotomy" src="slide12.swf" size="59598" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset11" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="19.2520003"/>
			</animationSteps>
			<notes>~ defined as ~</notes>
			<notesNormalized>~ defined as ~</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;~ defined as ~&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Precut sphincterotomy 
Precut is most frequently performed in high volume center
Early precut sphincterotomy (≤5 attempts, ≤ 5 min, ≤ 3 PD cannulations)
Improve cannulation success rate by 32%



Reduce post-ERCP pancreatitis up to 50%

Cennamo V. et al. Endoscopy 2010
Sundaralingam P. et al. Clin Gastro &amp; Hepatol 2015</text>
		</slide>
		<slide index="12" title="Repeat ERCP attempt following failed ERCP" titleNormalized="repeat ercp attempt following failed ercp" src="slide13.swf" size="79408" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset12" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="29.9990000"/>
			</animationSteps>
			<notes>Second ERCP attempt after a few days later, is another good option
In 9 studies, ~</notes>
			<notesNormalized>second ercp attempt after a few days later, is another good option
in 9 studies, ~</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Second ERCP attempt after a few days later, is another good option&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;In 9 studies, ~&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Repeat ERCP attempt following failed ERCP
Dumonceau JM, et al. Endoscopy 2018 
82%
Repeat ERCP was successful in 442 of 537 patients (82 %)
Repeat ERCP was more successful if it was repeated at least 2 days after 1st attempt, better patient sedation or referral to experienced endoscopists
The morbidity associated with the first and subsequent ERCPs was similar 
</text>
		</slide>
		<slide index="13" title="EUS-BD for difficult biliary cannulation" titleNormalized="eus-bd for difficult biliary cannulation" src="slide14.swf" size="91770" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset13" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="15.4480004"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>0.6% 
EUS-BD for difficult biliary cannulation 
GIE 2016
EUS-BD might be considered as a substitute for ERCP in a tertiary-care center
EUS-BD was required in only 0.6% of native papilla ERCPs</text>
		</slide>
		<slide index="14" title="EUS-BD for difficult biliary cannulation" titleNormalized="eus-bd for difficult biliary cannulation" src="slide15.swf" size="94954" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset14" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="15.0470003"/>
			</animationSteps>
			<notes>In this another study ~
 </notes>
			<notesNormalized>in this another study ~
</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;In this another study ~&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt; &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Tonozuka R. et al. GIE 2016 
EUS-BD for difficult biliary cannulation 
EUS-BD was required in only 0.5% of accessible papilla, and 3% with inclusion of inaccessible papilla and failed drainage after successful cannulation</text>
		</slide>
		<slide index="15" title="Accessible papilla, but difficult biliary cannulation" titleNormalized="accessible papilla, but difficult biliary cannulation" src="slide16.swf" size="17088" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset15" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="18.2510008"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Most of difficult biliary cannulation could be solved at high volume center with precut or 2nd attempt of ERCP with high success rate and without increasing AEs rate 

EUS-BD might be used as a substitute for ERCP, but should be considered as a 3rd option in selected cases 
Accessible papilla, but difficult biliary cannulation</text>
		</slide>
		<slide index="16" title="Malignant hilar obstruction" titleNormalized="malignant hilar obstruction" src="slide17.swf" size="138881" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset16" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="25.3579993"/>
			</animationSteps>
			<notes>In patients with unresectable malig hilar obstruction, 
There are ~
</notes>
			<notesNormalized>in patients with unresectable malig hilar obstruction, 
there are ~
</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;In patients with unresectable malig hilar obstruction, &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;There are ~&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Bilateral biliary drainages are frequently required for the drainage of &gt; 50% of liver volume in order to achieve successful outcome 






55-60%
30-35%
Several established options of bilateral drainage by ERCP	
Multiple plastic 
Malignant hilar obstruction 
SEMS, stent-by-stent
SEMS, stent-in-stent</text>
		</slide>
		<slide index="17" title="EUS-BD for Malignant hilar obstruction" titleNormalized="eus-bd for malignant hilar obstruction" src="slide18.swf" size="49403" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset17" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="21.4199995"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>EUS-BD for Malignant hilar obstruction 
Data on EUS-BD for malignant hilar obstruction are limited
EUS-HGS usually enables drainage of left IHD alone 
Bilateral drainage by EUS-BD is complicated and performed only in a few expert centers
Nakai Y, Isayama H, et al. Clin Endosc 2019</text>
		</slide>
		<slide index="18" title="Uncertain malignant biliary obstruction" titleNormalized="uncertain malignant biliary obstruction" src="slide19.swf" size="186822" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset18" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="26.2919993"/>
			</animationSteps>
			<notes>Sometimes, the cause of obstruction is uncertain before drainage
Detailed evaluation is possible with ~</notes>
			<notesNormalized>sometimes, the cause of obstruction is uncertain before drainage
detailed evaluation is possible with ~</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Sometimes, the cause of obstruction is uncertain before drainage&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Detailed evaluation is possible with ~&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Uncertain malignant biliary obstruction 
Evaluation of obstructive cause during the same session of drainage by ERCP 
Detailed cholangiogram
ERCP with cytology/biopsy 
Intraductal ultrasonography (IDUS)
Cholangioscopy 
Probe-based confocal laser endomicroscopy (p-CLE)</text>
		</slide>
		<slide index="19" title="Various options of ERCP stents" titleNormalized="various options of ercp stents" src="slide20.swf" size="299325" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset19" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="19.8189997"/>
			</animationSteps>
			<notes>EUS-BD with LAMS ; decrease bile leak, stent migration, and procedure time with one action system, but may increase food impaction   </notes>
			<notesNormalized>eus-bd with lams ; decrease bile leak, stent migration, and procedure time with one action system, but may increase food impaction</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;EUS-BD with LAMS ; decrease bile leak, stent migration, and procedure time with one action system, but may increase food impaction   &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Various options of ERCP stents
Plastic, pcSEMS, fcSEMS
1~3 stents 
Preoperative vs. palliative 
Anti-reflux
Anti-migrating
Drug-eluting stent</text>
		</slide>
		<slide index="20" title="Adjunctive therapy : PDT, RFA" titleNormalized="adjunctive therapy : pdt, rfa" src="slide21.swf" size="263095" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset20" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="13.3460001"/>
			</animationSteps>
			<notes>Can be applied easily through ERCP  for ~ </notes>
			<notesNormalized>can be applied easily through ercp for ~</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Can be applied easily through ERCP  for ~ &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Adjunctive therapy : PDT, RFA
Can be applied through ERCP for the palliation of cholestasis or improvement of stent patency and quality of life

Monga A, GE 2011;74:935-7</text>
		</slide>
		<slide index="21" title="Summary - Why ERCP First" titleNormalized="summary - why ercp first" src="slide22.swf" size="20500" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset21" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="24.1230005"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Summary - Why ERCP First 
Standardized technique and dedicated accessories 
High success rate by average-experienced endoscopists 
Detailed evaluation and tissue confirm at the same session of drainage 
Provision of additional diagnostic modalities such as IDUS, cholangioscopy, pCLE
Various stents 
Adjunctive therapy : RFA, PDT</text>
		</slide>
		<slide index="22" title="Summary - Why not EUS first" titleNormalized="summary - why not eus first" src="slide23.swf" size="21718" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset22" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="24.3569998"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Summary - Why not EUS first
EUS-BD approach in the primary setting is still at an early stage in terms of limited expertise, procedural volumes, and available evidence

Little is known about the potential variability in EUS-BD success rates and AEs between low- and high-volume EUS centers

Until recently, EUS-BD was reserved for cases of inaccessible papilla or failed ERCP
</text>
		</slide>
		<slide index="23" title="Issues for future strategy" titleNormalized="issues for future strategy" src="slide24.swf" size="17549" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset23" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="17.2830004"/>
			</animationSteps>
			<notes>Additional issues for ~ are as follows </notes>
			<notesNormalized>additional issues for ~ are as follows</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Additional issues for ~ are as follows &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Issues for future strategy 
High quality studies directly comparing the two methods in large numbers of patients to identify potential differences in ~
Particular subgroups : PC vs. CCA
Distal vs. proximal
Risk of specific adverse events 
Cost-effectiveness 
Re-intervention rate 
Long-term outcome</text>
		</slide>
		<slide index="24" title="Conclusion" titleNormalized="conclusion" src="slide25.swf" size="19094" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset24" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="15.0470003"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Conclusion 
ERCP should be the first modality for MBO because it provide more established methods and various options, and probably higher success rate at average volume endoscopy centers 

Primary EUS-BD can not be generalized yet until more evidences, dedicated devices and safer techniques are established 
</text>
		</slide>
		<slide index="25" title="Thank you for your kind attention" titleNormalized="thank you for your kind attention" src="slide26.swf" size="932219" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset25" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="1.6340000"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Thank you for your kind attention</text>
		</slide>
	</slides>
</presentation>
